Circulating FGF23 is not associated with cardiac dysfunction, atherosclerosis, infection or inflammation in hemodialysis patients

Fibroblast growth factor (FGF) 23 is a bone-derived hormone regulating serum inorganic phosphate (Pi) concentration. FGF23 is also involved in the development of chronic kidney disease (CKD)-mineral and bone disorder. Serum FGF23 concentration begins to increase early in the progression of CKD and c...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of bone and mineral metabolism 2020, Vol.38 (1), p.70-77
Hauptverfasser:	Takashi, Yuichi, Wakino, Shu, Minakuchi, Hitoshi, Ishizu, Masashi, Kuroda, Akio, Shima, Hisato, Tashiro, Manabu, Miya, Keiko, Okada, Kazuyoshi, Minakuchi, Jun, Kawashima, Shu, Matsuhisa, Munehide, Matsumoto, Toshio, Fukumoto, Seiji
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Arteriosclerosis Atherosclerosis Atherosclerosis - blood Atherosclerosis - complications Atherosclerosis - physiopathology Calcium Calcium (blood) Cardiomyocytes End-stage renal disease Female Fibroblast growth factor 23 Fibroblast Growth Factors - blood Heart - physiopathology Hemodialysis Humans Hypertrophy Infections Infections - blood Infections - complications Inflammation Inflammation - blood Inflammation - complications Kidney diseases Logistic Models Male Medicine Medicine & Public Health Metabolic Diseases Original Article Orthopedics Regression Analysis Renal Dialysis Risk factors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!